Related Experiment Video
Updated: Mar 12, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression
Yue Teng1, Xiaohang Zuo, Meng Hou
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, China.
Background:
Epigenetic abnormalities are increasingly observed in multiple malignancies, including epithelial ovarian cancer (EOC), and their effects can be significantly counteracted by tumor-suppressor microRNAs, namely epi-miRNAs. Here, we investigated the role of miR-29b, a well-established epi-miRNA, in the DNA methylation regulation of EOC cells.
Methods:
The correlation between miR-29b and DNMT3A/3B expression was evaluated by RT-qPCR, western blotting and immunohistochemical analysis. The functional roles of miR-29b and DNMT3A/3B were tested by anti-miRs and microRNA precursors. A luciferase reporter assay was employed to detect the direct binding of miR-29b to DNMT3A/3B 3' UTRs. Co-IP was utilized for investigating Id-1 binding activity.
Results:
miR-29b was negatively correlated with DNMT3A/3B expression at the cellular/histological levels. miR-29b silencing was correlated with increased DNMT3A/3B levels, whereasmiR-29b over-expression caused DNMT3A/3B down-regulation. Luciferase reporter assays confirmed that the miR-29b-mediated downregulation of DNMT3A/3Boccurred through the direct targeting of theirmRNAs'3'-UTRs,whereasBGS assays found that DNMT3A/3B knockdown increased miR-29b expression via CpG island promoter hypomethylation, thus suggesting a crucial crosstalk betweenmiR-29b and DNMT3A/3B via a double-negative feedback loop. Co-IP assay confirmed direct binding between DNMT3A and Id-1.
Conclusion:
Taken together, our study sheds light on a novel epigenetic circuitry regulating EOC progression and may provide novel options for miR-29b-based epi-therapeutic approaches for future EOC treatment.
Insights
This study reveals miR-29b regulates DNA methylation in ovarian cancer by targeting DNMT3A/3B. This epigenetic feedback loop offers potential for new miR-29b-based ovarian cancer therapies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic abnormalities are common in epithelial ovarian cancer (EOC).
- Tumor-suppressor microRNAs (epi-miRNAs) can counteract these abnormalities.
- miR-29b is a known epi-miRNA with potential roles in EOC.
Purpose of the Study:
- To investigate the role of miR-29b in DNA methylation regulation in EOC cells.
- To elucidate the relationship between miR-29b and DNA methyltransferases (DNMTs) in EOC.
Main Methods:
- Quantitative real-time PCR (RT-qPCR), western blotting, and immunohistochemistry assessed miR-29b and DNMT3A/3B expression.
- Functional roles were tested using anti-miRs and microRNA precursors.
- Luciferase reporter assays and Co-immunoprecipitation (Co-IP) investigated direct interactions.
Main Results:
- miR-29b expression was inversely correlated with DNMT3A/3B levels in EOC.
- miR-29b directly targeted DNMT3A/3B mRNAs, leading to their downregulation.
- A double-negative feedback loop was identified: DNMT3A/3B modulated miR-29b expression via DNA methylation, and miR-29b regulated DNMT3A/3B.
Conclusions:
- A novel epigenetic regulatory circuit involving miR-29b and DNMT3A/3B was uncovered in EOC.
- This crosstalk suggests potential for miR-29b-based therapeutic strategies for EOC treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

